SBIR-STTR Award

Computational Platform for Green Chemistry
Award last edited on: 11/4/14

Sponsored Program
SBIR
Awarding Agency
NIH : NIEHS
Total Award Amount
$149,182
Award Phase
1
Solicitation Topic Code
-----

Principal Investigator
Glenn John Myatt

Company Information

LeadScope Inc (AKA: Columbus Molecular Software)

1393 Dublin Road
Columbus, OH 43212
   (614) 675-3730
   info@leadscope.com
   www.leadscope.com
Location: Single
Congr. District: 15
County: Franklin

Phase I

Contract Number: 1R43ES022874-01A1
Start Date: 6/3/14    Completed: 5/31/15
Phase I year
2014
Phase I Amount
$149,182
The field of green chemistry was established in order to reduce or even eliminate any negative impact from the introduction of new chemical products such as new pesticides, cosmetics, or drugs to human health or the environment. Unfortunately, current approaches for testing chemicals are expensive, time-consuming and require the use and sacrifice of hundreds of animals which makes their routine use throughout product development impractical. New approaches to testing chemicals are being developed that are faster and cheaper. These tests rely on assays such as in vitro tests and computer models, and by using a tiered battery of these new tests, it will be eventually possible to make decision on safety throughout the entire chemical R&D process. Different testing approaches should provide an appropriate confidence level at the different phases of product development. This information will be used to make design decisions that mitigate any identified risks. The objective of this phase I proposal is to understand how a combination of these tests is able to predict specific effects related to the disruption of the hormonal system such as reproductive problem as well as whether any proposed chemicals are likely to persist in the water supply. These case studies will direct how to extend the methodology for the next phase of the project that will ultimately lead to a commercial computational platform. This offering will enable researchers to create new chemical products that are benign by design. The eventual use of this computer platform will reduce R&D costs as well enable the development of products with fewer adverse effects to human health and the environment.

Thesaurus Terms:
Acute;Adverse Effects;Animal Experiments;Animals;Base;Benign;Biodegradation;Biological;Biological Assay;Case Study;Chemical Industry;Chemical Structure;Chemicals;Chemistry;Chronic;Computer Simulation;Computers;Cosmetics;Cost;Coupled;Data;Databases;Decision Making;Design;Development;Disease;Drug Industry;Endocrine Disruption;Endocrine System;Ensure;Environment;Evaluation;Event;Functional Disorder;Goals;Hazard;Health;Human;In Vitro;In Vitro Assay;In Vitro Testing;In Vivo;Lead;Literature;Malignant Neoplasms;Marketing;Measures;Metabolism;Methodology;Modeling;Novel Strategies;Organ;Pesticides;Pharmaceutical Preparations;Phase;Process;Product Development;Productivity;Programs;Protocols Documentation;Public Health Relevance;Quantitative Structure-Activity Relationship;Reproductive;Research And Development;Research Personnel;Research Study;Risk;Safety;Series;Testing;Time;Tool;Toxic Effect;Training;Water Supply;

Phase II

Contract Number: ----------
Start Date: 00/00/00    Completed: 00/00/00
Phase II year
----
Phase II Amount
----